Related Experiment Video
Updated: May 10, 2025

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
Metronidazole-induced encephalopathy and polyneuropathy
Partha Sahu1, Nivedita Sharma2, Prasan Kumar Panda3
1General Medicine (ID Division), All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
Metronidazole can cause severe neurological side effects like peripheral neuropathy and encephalopathy, particularly with high doses or long-term use. Promptly stopping the medication can lead to significant symptom improvement.
Area of Science:
- Neurology
- Pharmacology
- Toxicology
Background:
- Metronidazole is an effective antibiotic, but prolonged or high-dose therapy can lead to serious side effects.
- Metronidazole-induced neurotoxicity, including peripheral neuropathy and encephalopathy, can be debilitating.
Purpose of the Study:
- To report a case of severe neurological sequelae following metronidazole treatment.
- To highlight the importance of recognizing metronidazole-induced neurotoxicity.
Main Methods:
- A case study of a middle-aged man treated with high-dose metronidazole for a liver abscess.
- Neurological assessment included nerve conduction studies (NCS) and magnetic resonance imaging (MRI).
Main Results:
- The patient developed dysarthria, ataxic gait, and sensory loss consistent with peripheral neuropathy.
- NCS confirmed axonal neuropathy, and MRI showed T2/FLAIR hyperintensities indicative of toxic encephalopathy.
- Symptoms significantly improved after discontinuing metronidazole.
Conclusions:
- High-dose or prolonged metronidazole therapy can cause severe neurological damage, including peripheral neuropathy and encephalopathy.
- Clinicians should maintain vigilance for neurotoxicity in patients receiving long-term or high-dose metronidazole.
- Early recognition and cessation of metronidazole are crucial for symptom recovery.
More Related Videos
Related Concept Videos
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...

